It has been reported that upregulation of B4GALT2 induces p53-mediated apoptosis in HeLa cells and reveals a relationship with cisplatin-resistance in ovarian cancer cells (Zhou, et al., 2008; Zhao, et al., 2017). Here, B4GALT2 is linked to ovarian carcinoma.